Valuation: Indegene Limited

Market Cap 156B 1.67B 1.52B 1.4B 1.27B 2.39B 2.48B 16.9B 6.69B 84.33B 6.28B 6.14B 266B P/E 2027 *
29.3x
P/E 2028 * 23x
Enterprise Value 150B 1.61B 1.46B 1.35B 1.22B 2.3B 2.38B 16.24B 6.42B 81.03B 6.03B 5.9B 256B EV / Sales 2027 *
3.3x
EV / Sales 2028 * 2.69x
Free-Float
44.55%
Yield 2027 *
0.43%
Yield 2028 * 0.52%
1 day+0.93%
1 week+6.30%
Current month+11.59%
1 month+11.30%
3 months+15.34%
6 months+28.39%
Current year+25.81%
1 week 614.75
Extreme 614.75
677
1 month 561.55
Extreme 561.55
677
Current year 414
Extreme 414
677
1 year 414
Extreme 414
677
3 years 414
Extreme 414
736.3
5 years 414
Extreme 414
736.3
10 years 414
Extreme 414
736.3
Manager TitleAgeSince
Corporate Officer/Principal - 1998-10-15
Chief Executive Officer 53 2022-11-02
Corporate Officer/Principal 63 2002-01-28
Director TitleAgeSince
Director/Board Member 56 1998-10-15
Director/Board Member 63 2002-01-28
Chairman 53 2022-11-02
Date Insider Type Main position Quantity % Market Cap. Importance
12/27/24 Buy

Chief Executive Officer

17,000 0.0071%
12/23/24 Buy

Founder

25,000 0.0104%
12/23/24 Buy

Founder

16,500 0.0069%
Change 5-day change 1-year change 3-year change Capi.($)
+0.90%+6.30%+29.39% - 1.67B
-2.27%-1.47%+27.94%+67.00% 786B
-0.87%-1.37%+20.92%+62.20% 88.23B
-1.11%-2.03%+34.21%+125.07% 67.03B
-4.40%-7.33%+34.67%+36.29% 47.94B
-1.22%-1.14%-6.11%+2.78% 48.27B
-1.60%-1.60%-0.62%-49.78% 33.15B
-0.07%-0.86%+30.32%+20.17% 33.04B
-1.02%-20.87%+23.33%+459.85% 31.07B
-2.04%-1.59%+64.97%+94.28% 28.94B
Average -1.37%-3.11%+25.90%+90.87% 117B
Weighted average by Cap. -2.02%-2.18%+26.69%+72.56%

Financials

2027 *2028 *
Net sales 45.53B 487M 442M 409M 369M 696M 723M 4.92B 1.95B 24.57B 1.83B 1.79B 77.63B 51.98B 556M 505M 467M 421M 795M 825M 5.62B 2.22B 28.05B 2.09B 2.04B 88.61B
Net income 5.35B 57.23M 51.96M 47.99M 43.3M 81.74M 84.87M 578M 229M 2.89B 215M 210M 9.12B 6.79B 72.71M 66.01M 60.97M 55.01M 104M 108M 735M 291M 3.67B 273M 267M 11.58B
Net Debt -6.13B -65.6M -59.56M -55.02M -49.63M -93.7M -97.29M -663M -262M -3.31B -246M -241M -10.45B -16.25B -174M -158M -146M -132M -248M -258M -1.76B -695M -8.77B -652M -639M -27.7B
Projected Income Statement - Annual - Indegene Limited
Logo Indegene Limited
Indegene Limited is an India-based tech-native, life sciences commercialization company. The Company provides digital-led commercialization services for the life sciences industry, including biopharmaceutical, emerging biotech, and medical devices companies. Its segments include Enterprise Medical Solutions, Enterprise Commercial Solutions, Brand Activation, and Others. The Enterprise Commercial Solutions business unit caters to the digital marketing operations of life sciences companies. The Enterprise Medical Solutions consolidates large-scale regulatory and medical operations for life sciences companies. The Brand Activation segment offers promotion of biopharmaceutical products and medical devices to HCPs for life sciences companies across channels. It provides customized marketing campaigns through a comprehensive portfolio of proprietary program offerings. Others mainly consist of consultancy and clinical business.
Employees
4,687
Date Price Change Volume
26-11-18 ₹654.60 +0.90% 262,110
26-11-17 ₹648.75 -2.06% 351,257
26-11-16 ₹662.40 -0.57% 774,394
26-11-13 ₹666.20 +0.02% 1,264,855
26-11-12 ₹666.05 +8.12% 2,863,335
Trader
Investor
Global
Quality
ESG MSCI
-
MarketScreener Ratings - Indegene Limited
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
8
Last Close Price
648.75INR
Average target price
696.62INR
Spread / Average Target
+7.38%
  1. Stock Market
  2. Stocks
  3. INDGN Stock